Back to
Man Group plc
CCCC
Showing 6 of 15 quarters
Position history for
Man Group plc's holdings in C4 Therapeutics, Inc.
Yes. Man Group holds 408,648 shares of CCCC (C4 Therapeutics), worth $1.9M, as of its Q2 2026 13F filing. It increased the position by 152,180 shares (+59.3%) from Q1 2026. Man Group has held CCCC since Q1 2025, across 6 quarterly 13F filings.
Current Value
$1.9M
Current Shares
408,648
Total Value Change
+$1.8M
Total Shares Change
+323,025
Quarter-by-Quarter History